HBK INVESTMENTS L P - VERTEX PHARMACEUTICALS INC ownership

VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of VERTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,029,0004,7000.01%
Other shareholders
VERTEX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 163,900$35,992,0000.03%
SIMPLEX TRADING, LLC 85,900$18,863,0000.02%
SG Americas Securities, LLC 100,000$510,0000.00%
IMC-Chicago, LLC 10,700$2,350,0000.00%
JPMORGAN CHASE & CO 39,100$8,586,0000.00%
Allianz Asset Management GmbH 6,000$1,318,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VERTEX PHARMACEUTICALS INC shareholders